Pharmabiz

UK to provide 12 new projects for obesity care using £85 million funding

UK to provide 12 new projects for obesity care using £85 million funding: London Tuesday, June 30, 2026, 18:00 Hrs [IST] Patients in regions across the UK will be given new and e ...
Pharmabiz

Sisram Medical announces China manufacturing facility in Miyun, Beijing commences operations as first locally produced EBD, Alma Rejuve rolls off the line

Sisram Medical announces China manufacturing facility in Miyun, Beijing commences operations as first locally produced EBD, Alma Rejuve rolls off the line: Hong Kong Tuesday, June ...
Pharmabiz

J.P. Nadda launches Aarogya Setu 2.0 and other digital initiatives for health sector

J.P. Nadda launches Aarogya Setu 2.0 and other digital initiatives for health sector: Our Bureau, Mumbai Tuesday, June 30, 2026, 11:15 Hrs [IST] Union Minister for Health and Fami ...
Pharmabiz

China NMPA holds meeting on vaccine regulatory QMS

To advance the development of China's National Regulatory Authority (NRA) for vaccines and further enhance the country's vaccine regulatory capacity, the National Medical Products Administration (NMPA ...
Pharmabiz

Onco-Innovations begins three-species hepatocyte and microsome metabolism studies for ONC010

Onco-Innovations begins three-species hepatocyte and microsome metabolism studies for ONC010: Vancouver, Canada Tuesday, June 30, 2026, 17:00 Hrs [IST] Onco-Innovations Limited, a ...
Pharmabiz

Cadila Pharmaceuticals signs MoU with Wellesta Holdings to accelerate growth

Cadila Pharmaceuticals signs MoU with Wellesta Holdings to accelerate growth: Our Bureau, Mumbai Tuesday, June 30, 2026, 15:15 Hrs [IST] Cadila Pharmaceuticals, one of India’s l ...
Pharmabiz

Otsuka Pharma announces joint research with Tohoku University on water turnover

Otsuka Pharma announces joint research with Tohoku University on water turnover: Tokyo Tuesday, June 30, 2026, 15:00 Hrs [IST] Otsuka Pharmaceutical Co., Ltd. (Otsuka) established ...
Pharmabiz

Viridian Therapeutics receives US FDA approval for Lumvoa for the treatment of thyroid eye disease

Viridian Therapeutics receives US FDA approval for Lumvoa for the treatment of thyroid eye disease: Waltham, Massachusetts Tuesday, June 30, 2026, 13:00 Hrs [IST] Viridian Therape ...
Pharmabiz

AstraZeneca announces positive results from MULBERRY phase III trial of efzimfotase alfa, an investigational enzyme replacement therapy

AstraZeneca announces positive results from MULBERRY phase III trial of efzimfotase alfa, an investigational enzyme replacement therapy: Cambridge, UK Tuesday, June 30, 2026, 11:0 ...
Pharmabiz

Jubilant Pharmova receives USFDA tentative approval for Pantoprazole oral suspension

Jubilant Pharmova receives USFDA tentative approval for Pantoprazole oral suspension: Our Bureau, Mumbai Tuesday, June 30, 2026, 11:30 Hrs [IST] Jubilant Pharmova Limited announce ...
Pharmabiz

Health Minister launches ‘SUMAN Roadmap 2030’ to strengthen maternal and newborn Healthcare

Health Minister launches ‘SUMAN Roadmap 2030’ to strengthen maternal and newborn Healthcare: Our Bureau, Mumbai Tuesday, June 30, 2026, 11:20 Hrs [IST] Union Minister of Healt ...
Pharmabiz

Aurobindo Pharma completes acquisition of Lannett Company

Aurobindo Pharma USA Inc., (APUSA), a wholly owned subsidiary of Aurobindo Pharma Limited, announce the completion of its acquisition of Lannett Company, Inc., USA from Lannett Seller Holdco, Inc., ...